The Howard University College of Pharmacy, in collaboration with the Food and Drug Ad-ministration (FDA) and GlaxoSmithKline, announces the creation of a new fellowship centered on regulatory affairs and policy
Browsing: FDA
The FDA continues to work with stakeholders—including patients, academics and companies developing treatments—to improve therapeutic options for people living with SCD.
The FDA has just released a report citing clinical study evidence that the naproxen painkiller Aleve has a lower cardiac risk than ibuprofen rivals such as Motrin and Advil. An advisory committee made up of doctors and…